SyntheticMR’s Receives Regulatory Clearance for SyMRI in the UK
SyntheticMR announced today that their quantitative imaging software solution SyMRI has received regulatory clearance in the UK. It can now be sold and distributed in this market.“It’s very exciting to see our company’s continued growth. This regulatory clearance is one step closer to making SyMRI available all over the globe.” says Kyle Frye, CCO of SyntheticMR. “We look forward to bringing SyMRI to the UK market and to show how it can transform the clinical workflow in this region and become the standard of care.” SyMRI NEURO is a quantitative imaging software solution that measures